(13:33 GMT) MoonLake Immunotherap Price Target Raised to $29.00/Share From $24.00 by Leerink Partners
Dow Jones Newswires
MoonLake Immunotherap Is Maintained at Outperform by Leerink Partners
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:MLTX
- Language
- English